Dr Reddys Laboratories (RDY) Total Non-Current Liabilities (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Total Non-Current Liabilities of $1.29 million for the quarter ended Jun 30, 2026, down 34.4% from $1.96 million a year earlier but up 8.1% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Total Non-Current Liabilities came in at $1 million, down 50.0% from the prior year.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 0.0% (years ended Mar 2021 to Mar 2026).
- In prior years, Dr Reddys Laboratories' Total Non-Current Liabilities was $2 million in the year ended Mar 31, 2025 (+100.0%), $1 million in the year ended Mar 31, 2024 (unchanged), $1 million in the year ended Mar 31, 2023 (unchanged) and $1 million in the year ended Mar 31, 2022 (unchanged).
- Quarterly Total Non-Current Liabilities has run from a low of $652,224 in the quarter ended Sep 30, 2022 to a high of $1.98 million in the quarter ended Sep 30, 2025 over five years.
- On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last three quarters, with growth averaging 65.8% over the last eight quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was the quarter ended Jun 30, 2025, with growth of 168.4%; the weakest was the quarter ended Jun 30, 2026, with a decline of 34.4%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $1.19 million (quarter ended Mar 31, 2026), $1.18 million (quarter ended Dec 31, 2025) and $1.98 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Dr Reddys Laboratories | 10.73 Bn | 9.91 Bn | 396.53 Mn | 1.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.98 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.79 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 731,250.29 |
| Mar 31, 2024 | 734,534.51 |
| Dec 31, 2023 | 732,603.69 |
| Sep 30, 2023 | 713,722.21 |
| Jun 30, 2023 | 730,299.77 |
| Mar 31, 2023 | 717,726.28 |
| Dec 31, 2022 | 694,255.80 |
| Sep 30, 2022 | 652,223.74 |
| Jun 30, 2022 | 713,263.93 |
| Mar 31, 2022 | 758,047.20 |
| Dec 31, 2021 | 774,102.60 |
| Sep 30, 2021 | 782,778.69 |
API Access
Dr Reddys Laboratories Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();